实用药物与临床
實用藥物與臨床
실용약물여림상
PRACTICAL PHARMACY AND CLINICAL REMEDIES
2014年
6期
697-699
,共3页
朱建峰%陈学梅%袁旻池%陈波%何纯
硃建峰%陳學梅%袁旻池%陳波%何純
주건봉%진학매%원민지%진파%하순
缺血性心肌病%心力衰竭%卡维地洛%曲美他嗪%左室功能%QT间期离散度
缺血性心肌病%心力衰竭%卡維地洛%麯美他嗪%左室功能%QT間期離散度
결혈성심기병%심력쇠갈%잡유지락%곡미타진%좌실공능%QT간기리산도
Ischemic cardiomyopathy%Heart failure%Carvedilol%Trimetazidine%Left ventricular function%QTd
目的:探讨卡维地洛联合曲美他嗪对缺血性心肌病心衰患者左室功能及QT间期离散度的影响。方法将我院诊治的80例缺血性心肌病心衰患者随机分入对照组与治疗组,对照组患者接受卡维地洛口服,治疗组患者接受卡维地洛联合曲美他嗪口服,疗程6个月。比较两组左室功能、血压、心率及QT间期离散度的改变。结果治疗6个月后,治疗组左室舒张末期内径( LVEDd )、左室射血分数( LVEF )、室间隔厚度(IVSD)、左室重量指数(LVMI)及左室后壁(PWTD)显著优于对照组(P<0.05);与对照组相比,治疗组QT间期离散度(QTd)及心率校正 QT 间期(QTcd)显著下降(P <0.05);两组治疗后心率、收缩压(SBP)及舒张压(DBP)差异无统计学意义(P>0.05)。结论卡维地洛联合曲美他嗪治疗缺血性心肌病心衰可显著改善患者左室功能,缩短QTd及QTcd。
目的:探討卡維地洛聯閤麯美他嗪對缺血性心肌病心衰患者左室功能及QT間期離散度的影響。方法將我院診治的80例缺血性心肌病心衰患者隨機分入對照組與治療組,對照組患者接受卡維地洛口服,治療組患者接受卡維地洛聯閤麯美他嗪口服,療程6箇月。比較兩組左室功能、血壓、心率及QT間期離散度的改變。結果治療6箇月後,治療組左室舒張末期內徑( LVEDd )、左室射血分數( LVEF )、室間隔厚度(IVSD)、左室重量指數(LVMI)及左室後壁(PWTD)顯著優于對照組(P<0.05);與對照組相比,治療組QT間期離散度(QTd)及心率校正 QT 間期(QTcd)顯著下降(P <0.05);兩組治療後心率、收縮壓(SBP)及舒張壓(DBP)差異無統計學意義(P>0.05)。結論卡維地洛聯閤麯美他嗪治療缺血性心肌病心衰可顯著改善患者左室功能,縮短QTd及QTcd。
목적:탐토잡유지락연합곡미타진대결혈성심기병심쇠환자좌실공능급QT간기리산도적영향。방법장아원진치적80례결혈성심기병심쇠환자수궤분입대조조여치료조,대조조환자접수잡유지락구복,치료조환자접수잡유지락연합곡미타진구복,료정6개월。비교량조좌실공능、혈압、심솔급QT간기리산도적개변。결과치료6개월후,치료조좌실서장말기내경( LVEDd )、좌실사혈분수( LVEF )、실간격후도(IVSD)、좌실중량지수(LVMI)급좌실후벽(PWTD)현저우우대조조(P<0.05);여대조조상비,치료조QT간기리산도(QTd)급심솔교정 QT 간기(QTcd)현저하강(P <0.05);량조치료후심솔、수축압(SBP)급서장압(DBP)차이무통계학의의(P>0.05)。결론잡유지락연합곡미타진치료결혈성심기병심쇠가현저개선환자좌실공능,축단QTd급QTcd。
Objective To explore the effect of carvedilol combined with trimetazidine on left ventricular func-tion and QTd in patients with ischemic cardiomyopathy complicated with heart failure. Methods 80 patients with is-chemic cardiomyopathy complicated with heart failure were randomly divided into control group and treatment group. Control group received carvedilol treatment and treatment group was given carvedilol combined with trimetazidine. The course of treatment was 6 months. Left ventricular function,blood pressure,heart rate and QTd were compared between the two groups. Results After 6 months′treatment,LVEDd,LVEF,IVSD,LVMI and PWTD of treatment group were superior to those of control group (P<0. 05);Compared with control group,QTd and QTcd of treatment group greatly decreased (P<0. 05). There were no significant difference of heart failure,SBP and DBP between the two groups (P>0. 05 ) . Conclusion Carvedilol combined with trimetazidine for ischemic cardiomyopathy complicated with heart failure can greatly improve the left ventricular function and induce QTd.